{
"id":"mk19_a_np_q061",
"number":61,
"bookId":"np",
"correctAnswer":"B",
"title":"Question 61",
"stimulus":[
{
"type":"p",
"hlId":"2957f1",
"children":[
"A 62-year-old woman is evaluated during a follow-up visit for hypertension and chronic kidney disease. Medical history is otherwise unremarkable. Medications are losartan and amlodipine. The patient is adherent to her medication regimen and low sodium diet."
]
},
{
"type":"p",
"hlId":"c1592d",
"children":[
"On physical examination, blood pressure is 148/94 mm Hg in both arms, pulse rate is 65/min, and respiration rate is 18/min. BMI is 30. Neck examination shows jugular venous distension. Cardiac examination reveals an S",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"4"
]
},
" gallop. Lungs are clear to auscultation. There is 1+ pitting edema over the pretibial lower extremities and ankles bilaterally. The remainder of the examination is unremarkable."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"6827e3",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Bicarbonate, serum",
"children":[
"Bicarbonate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"f1e327",
"class":"cell text l",
"children":[
"22 mEq/L (22 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"34f471",
"class":"cell text l",
"children":[
"2.6 mg/dL (229.8 µmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"e92687",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Potassium, serum",
"children":[
"Potassium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"028d9b",
"class":"cell text l",
"children":[
"4.9 mEq/L (4.9 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"b99276",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Electrolytes, Sodium, serum",
"children":[
"Sodium"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"1fd2c7",
"class":"cell text l",
"children":[
"136 mEq/L (136 mmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"58e613",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Albumin-creatinine ratio, urine",
"children":[
"Urine albumin-creatinine ratio"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"b8cacc",
"class":"cell text l",
"children":[
"1500 mg/g"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"77db81",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Glomerular filtration rate (GFR), urine",
"children":[
"Estimated glomerular filtration rate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"20d29c",
"class":"cell text l",
"children":[
"24 mL/min/1.73 m",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
" "
]
}
]
}
]
}
]
}
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"78ff87",
"children":[
"Which of the following is the most appropriate additional treatment?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Carvedilol"
}
},
{
"letter":"B",
"text":{
"__html":"Furosemide"
}
},
{
"letter":"C",
"text":{
"__html":"Hydralazine"
}
},
{
"letter":"D",
"text":{
"__html":"Lisinopril"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"010c6b",
"children":[
"A loop diuretic such as furosemide is indicated for treating hypertension in patients with advanced chronic kidney disease."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"dba8ce",
"children":[
"The most appropriate additional treatment for this patient's antihypertensive medication regimen is furosemide (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
"). ACE inhibitors or angiotensin receptor blockers (ARBs) are first-line medications for patients with advanced chronic kidney disease (CKD) or proteinuric CKD. Calcium channel blockers reduce albuminuria and slow the decline in kidney function but should be combined with an ACE inhibitor or ARB. Diuretics are the backbone of hypertension management in patients with CKD because of increased extracellular volume. This patient has an elevated blood pressure not controlled to a target goal of <130/80 mm Hg in the setting of stage G4 CKD and evidence of a sodium-retentive state based on the presence of jugular venous distention and lower extremity edema. A thiazide diuretic will unlikely be effective, as her estimated glomerular filtration rate is <30 mL/min/1.73 m",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"2"
]
},
". Therefore, a loop diuretic, such as furosemide, two or three times daily, is indicated for management of this patient's hypertension. Suboptimal blood pressure control in patients with sodium-retentive, edematous conditions, such as advanced CKD, heart failure, and cirrhosis, is frequently the result of not including a diuretic, which ensures that extracellular volume expansion is prevented or treated."
]
},
{
"type":"p",
"hlId":"d85e45",
"children":[
"Without a compelling indication such as heart failure or recent myocardial infarction, the addition of a β-blocker such as carvedilol (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") to this patient's treatment regimen is not appropriate. Additionally, a β-blocker will not reduce this patient's expanded extracellular volume, thus limiting its ability to reduce the blood pressure."
]
},
{
"type":"p",
"hlId":"165245",
"children":[
"Similarly, hydralazine (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") is not indicated at this time because it will likely increase the patient's already expanded extracellular volume, resulting in inadequate blood pressure control."
]
},
{
"type":"p",
"hlId":"35775b",
"children":[
"Although the patient has CKD and albuminuria, adding lisinopril (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
"), an ACE inhibitor, to the patient's antihypertensive medication regimen, which already includes losartan, an ARB, is not the appropriate treatment. Combination therapy with an ACE inhibitor and ARB may result in adverse events, such as acute kidney injury and hyperkalemia, and does not improve cardiovascular outcomes compared with treatment with an ACE inhibitor or ARB alone."
]
}
],
"relatedSection":"mk19_a_np_s4_7_2_3_1",
"objective":{
"__html":"Treat hypertension with a loop diuretic in advanced chronic kidney disease."
},
"references":[
[
"Kalaitzidis RG, Elisaf MS. Treatment of hypertension in chronic kidney disease. Curr Hypertens Rep. 2018;20:64. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29892833",
"target":"_blank"
},
"children":[
"PMID: 29892833"
]
},
" doi:10.1007/s11906-018-0864-0"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
"A":7,
"B":81,
"C":6,
"D":5,
"E":0
},
"hlIds":[
"2957f1",
"c1592d",
"a462a3",
"6827e3",
"f1e327",
"f461b2",
"34f471",
"e92687",
"028d9b",
"b99276",
"1fd2c7",
"58e613",
"b8cacc",
"77db81",
"20d29c",
"78ff87",
"010c6b",
"dba8ce",
"d85e45",
"165245",
"35775b"
]
}